The wound care management market comprises of dressings, equipment and other aids to prevent and treat wounds and quicken or promote wound healing. Wound dressing involves use of dressing products combined with drug formulations to provide enhanced healing properties. GlobalData uses proprietary data and analytics to provide a comprehensive report on the wound dressings devices market, including market shares of different players within Brazil. Buy the latest report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Brazil Wound Dressings Market Share

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

In 2022, GlobalData’s Market Model methodology determined that the leading player in the wound dressings market in Brazil was Molnlycke Health Care followed by ConvaTec Group, Smith & Nephew, 3M, B. Braun Melsungen, Coloplast and Urgo.

Wound dressings are majorly used for the treatment of chronic wounds where they provide a moist and active dressings environment for optimum healing. Advanced wound dressings are also used for treating acute wounds such as surgical procedures, burns, and traumatic wounds. This category includes semi-permeable films, foams, hydrofibers, hydrocolloids, hydrogels, alginates, collagens.

Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the wound dressings devices market within Brazil was expected to be over $80m in 2022.

For the latest complete market share analysis of wound dressings device market in Brazil, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.